121 related articles for article (PubMed ID: 9291400)
1. Role of splenectomy in chronic lymphocytic leukemia.
Cusack JC; Seymour JF; Lerner S; Keating MJ; Pollock RE
J Am Coll Surg; 1997 Sep; 185(3):237-43. PubMed ID: 9291400
[TBL] [Abstract][Full Text] [Related]
2. Splenectomy in advanced chronic lymphocytic leukemia: a single institution experience with 50 patients.
Neal TF; Tefferi A; Witzig TE; Su J; Phyliky RL; Nagorney DM
Am J Med; 1992 Oct; 93(4):435-40. PubMed ID: 1415307
[TBL] [Abstract][Full Text] [Related]
3. Case/control study of the role of splenectomy in chronic lymphocytic leukemia.
Seymour JF; Cusack JD; Lerner SA; Pollock RE; Keating MJ
J Clin Oncol; 1997 Jan; 15(1):52-60. PubMed ID: 8996124
[TBL] [Abstract][Full Text] [Related]
4. Role of splenectomy in chronic lymphocytic leukaemia with massive splenomegaly and cytopenia.
Majumdar G; Singh AK
Leuk Lymphoma; 1992 May; 7(1-2):131-4. PubMed ID: 1472923
[TBL] [Abstract][Full Text] [Related]
5. Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cortes J; O'Brien S; Loscertales J; Kantarjian H; Giles F; Thomas D; Koller C; Keating M
Cancer; 2001 Oct; 92(8):2016-22. PubMed ID: 11596014
[TBL] [Abstract][Full Text] [Related]
6. Splenectomy in advanced chronic lymphocytic leukemia.
Thiruvengadam R; Piedmonte M; Barcos M; Han T; Henderson ES
Leukemia; 1990 Nov; 4(11):758-60. PubMed ID: 2232888
[TBL] [Abstract][Full Text] [Related]
7. Autoimmune thrombocytopenia due to chronic lymphocytic leukemia treated with fludarabine.
Wells T; Kovacs MJ
Ann Pharmacother; 2003 May; 37(5):671-4. PubMed ID: 12708944
[TBL] [Abstract][Full Text] [Related]
8. Splenectomy for hypersplenism in chronic lymphocytic leukaemia and malignant non-Hodgkin's lymphoma.
Delpero JR; Houvenaeghel G; Gastaut JA; Orsoni P; Blache JL; Guerinel G; Carcassonne Y
Br J Surg; 1990 Apr; 77(4):443-9. PubMed ID: 2340397
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features.
Mauro FR; Foa R; Cerretti R; Giannarelli D; Coluzzi S; Mandelli F; Girelli G
Blood; 2000 May; 95(9):2786-92. PubMed ID: 10779422
[TBL] [Abstract][Full Text] [Related]
10. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.
Molica S; De Rossi G; Luciani M; Levato D
Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755
[TBL] [Abstract][Full Text] [Related]
11. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
12. A phase II study of cladribine treatment for fludarabine refractory B cell chronic lymphocytic leukemia: results from CALGB Study 9211.
Byrd JC; Peterson B; Piro L; Saven A; Vardiman JW; Larson RA; Schiffer C
Leukemia; 2003 Feb; 17(2):323-7. PubMed ID: 12592330
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience.
Montserrat E; Lopez-Lorenzo JL; Manso F; Martin A; Prieto E; Arias-Sampedro J; Fernandez MN; Oyarzabal FJ; Odriozola J; Alcala A; Garcia-Conde J; Guardia R; Bosch F
Leuk Lymphoma; 1996 May; 21(5-6):467-72. PubMed ID: 9172812
[TBL] [Abstract][Full Text] [Related]
14. [Treatment with fludarabine of chronic refractory lymphoid leukemia].
Herrero M; Cabrera JR; Briz M; Forés R; Díez JL; Regidor C; Sanjuán I; Fernández MN
Sangre (Barc); 1995 Apr; 40(2):115-9. PubMed ID: 7784940
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.
Di Raimondo F; Giustolisi R; Lerner S; Cacciola E; O'Brien S; Kantarjian H; Keating MJ
Ann Oncol; 2001 May; 12(5):621-5. PubMed ID: 11432619
[TBL] [Abstract][Full Text] [Related]
16. Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup study.
Martell RE; Peterson BL; Cohen HJ; Petros WP; Rai KR; Morrison VA; Elias L; Shepherd L; Hines J; Larson RA; Schiffer CA; Hurwitz HI
Cancer Chemother Pharmacol; 2002 Jul; 50(1):37-45. PubMed ID: 12111110
[TBL] [Abstract][Full Text] [Related]
17. Splenectomy in mantle cell lymphoma with leukaemia: a comparison with chronic lymphocytic leukaemia.
Ruchlemer R; Wotherspoon AC; Thompson JN; Swansbury JG; Matutes E; Catovsky D
Br J Haematol; 2002 Sep; 118(4):952-8. PubMed ID: 12199772
[TBL] [Abstract][Full Text] [Related]
18. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of DT fusion protein denileukin diftitox in patients with fludarabine-refractory chronic lymphocytic leukemia.
Frankel AE; Fleming DR; Hall PD; Powell BL; Black JH; Leftwich C; Gartenhaus R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3555-61. PubMed ID: 14506141
[TBL] [Abstract][Full Text] [Related]
20. Chronic lymphocytic leukemia in the recent 10 years and treatment effects of Fludarabin.
Kermani IA; Dehdilani M; Dolatkhah R
Asian Pac J Cancer Prev; 2007; 8(3):367-71. PubMed ID: 18159969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
